focus -WSS

focus

author：comprehensive 2025-10-02 22:26:37 - browse：28813

ESMO signage in Madrid. — At ESMO 2023, antibody-drug conjugates were featured prominently. Andrew Joseph/STAT

MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting, a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates.

The conference opened to the news that Merck had signed one of the biggest licensing deals in industry history — worth up to $22 billion — to partner on three of the compounds from ADC specialist Daiichi Sankyo. GSK followed up with an ADC licensing announcement of its own (if a much smaller one). Multiple ADC studies were presented at the meeting’s top sessions. ADCs were, in short, the belle of the cancer research ball.

The thing is, ADCs are actually quite an old approach.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Pfizer plans to depart BIO

focus

knowledge

WSS

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Pregnancy discrimination could be enabled by AI

Even great ERs can’t make up for American health disparities

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

STAT letters to the editor on burnt

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

focus

focus

focus

Walensky prepares to leave CDC — and Congress — behind

FDA drug safety: Singulair case shows systemic surveillance flaws

Hepatitis C has a cure — but many Americans still lack access to it

Commercial surrogacy can be ethical, despite pope’s claims

23andMe had bad news about my health. I wish a person had delivered it

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

23andMe had bad news about my health. I wish a person had delivered it

Apple Vision Pro: A first look at health apps on the new VR headset

Sports medicine is finally prioritizing gender equality

Teach medical students about patients with intellectual disabilities

leisure time

Pfizer plans to depart BIO

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

General Catalyst, Summa Health deal will turn on physician buy

Even great ERs can’t make up for American health disparities

Pfizer plans to depart BIO

Spinal cord stimulation reduces pain in amputees, study finds

explore

focus

knowledge

entertainment